{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:14:25Z","timestamp":1777601665331,"version":"3.51.4"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2022-0036_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Despite remarkable development of new therapeutic strategies to improve survival rates and treatment of patients with cancer, there are still many limitations in management of patients with distant metastasis breast cancer. Therefore, the aim of this study was to investigate a novel method to enhance therapeutic efficacy of Apatinib (as a chemotherapeutic agent) by co\u2010administration of Curcumin (as a bioactive herbal compound) in breast cancer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2022-0036_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Effects of Apatinib, Curcumin, and their combinations (Apa\u2010Cur) was evaluated on viability and proliferation of breast cell line (MCF7) by MTT assay. Moreover, effects of Apatinib, Curcumin, and Apa\u2010Cur was investigated on apoptosis rate in the cancer cells. Expression levels of apoptosis-related genes (\n                      <jats:italic>BAX<\/jats:italic>\n                      ,\n                      <jats:italic>SMAC<\/jats:italic>\n                      ,\n                      <jats:italic>BCL2<\/jats:italic>\n                      , and\n                      <jats:italic>SURVIVIN<\/jats:italic>\n                      ) in treated cancer cells and untreated controls were evaluated using the Real-Time PCR method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2022-0036_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The obtained results showed that all treatments of Apatinib, Curcumin, and Apa\u2010Cur significantly decreased viability and proliferation of the breast cancer cells in a concentration\u2010 and time\u2010dependent manner. However, anti-proliferation activity of Apa\u2010Cur combination was significantly higher than Apatinib and Curcumin treatment alone. In addition, Apatinib, Curcumin, and Apa\u2010Cur increased apoptosis percentage in the treated cancer cells through regulation of apoptosis-related genes expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2022-0036_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In general, Apa\u2010Cur combination therapy exerts more profound anti-proliferation effects on breast cancer cell than Apatinib or Curcumin monotherapy. However, further studies are required to identify other possible signaling pathways and mechanisms involved in the anticancer effects of Apatinib, Curcumin, and Apa\u2010Cur.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2022-0036","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T06:47:26Z","timestamp":1662187646000},"page":"27-32","source":"Crossref","is-referenced-by-count":5,"title":["Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells"],"prefix":"10.1515","volume":"44","author":[{"given":"Mahdi","family":"Farhoudi Sefidan Jadid","sequence":"first","affiliation":[{"name":"Department of Biology, Faculty of Basic Sciences , University of Maragheh , Maragheh , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Jahangirzadehd","sequence":"additional","affiliation":[{"name":"Department of Genetics, Tabriz Branch , Islamic Azad University , Tabriz , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Behroozi","sequence":"additional","affiliation":[{"name":"Research Center for Cancer Screening and Epidemiology , AJA University of Medical Sciences , Tehran , Iran"},{"name":"Department of Genetics and Advanced Medical Technology , AJA University of Medical Sciences , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"2025121207235722323_j_hmbci-2022-0036_ref_001","doi-asserted-by":"crossref","unstructured":"Li, S, Wang, Y, Feng, C, Wu, G, Ye, Y, Tian, J. Calycosin inhibits the migration and invasion of human breast cancer cells by down-regulation of foxp3 expression. Cell Physiol Biochem 2017;44:1775\u2013844. https:\/\/doi.org\/10.1159\/000485784.","DOI":"10.1159\/000485784"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_002","unstructured":"Soheilyfar, S, Velashjerdi, Z, Hajizadeh, YS, Maroufi, NF, Amini, Z, Khorrami, A, et al.. In vivo and in\u00a0vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer. J Buon 2018;23:1290\u20136."},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_003","doi-asserted-by":"crossref","unstructured":"Amoodizaj, FF, Baghaeifar, S, Taheri, E, Jadid, MFS, Safi, M, Sani, NS, et al.. Enhanced anticancer potency of doxorubicin in combination with Curcumin in gastric adenocarcinoma. J Biochem Mol Toxicol 2020;34:22486. https:\/\/doi.org\/10.1002\/jbt.22486.","DOI":"10.1002\/jbt.22486"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_004","doi-asserted-by":"crossref","unstructured":"Isazadeh, A, Hajazimian, S, Shadman, B, Safaei, S, Bedoustani, AB, Chavoshi, R, et al.. Anti-cancer effects of probiotic lactobacillus acidophilus for colorectal cancer cell line caco-2 through apoptosis induction. Pharm Sci 2020;27:262\u20137. https:\/\/doi.org\/10.34172\/ps.2020.52.","DOI":"10.34172\/PS.2020.52"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_005","doi-asserted-by":"crossref","unstructured":"Jadid, MF, Aghaei, E, Taheri, E, Seyyedsani, N, Chavoshi, R, Abbasi, S, et al.. Melatonin increases the anticancer potential of doxorubicin in Caco-2 colorectal cancer cells. Environ Toxicol 2021;36:1061\u20139. https:\/\/doi.org\/10.1002\/tox.23105.","DOI":"10.1002\/tox.23105"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_006","doi-asserted-by":"crossref","unstructured":"Shah, A, Kuddushi, M, Rajput, S, El Seoud, OA, Malek, NI. Ionic liquid-based catanionic coacervates: novel microreactors for membrane-free sequestration of dyes and Curcumin. ACS Omega 2018;3:17751\u201361. https:\/\/doi.org\/10.1021\/acsomega.8b02455.","DOI":"10.1021\/acsomega.8b02455"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_007","doi-asserted-by":"crossref","unstructured":"Jadid, MF, Shademan, B, Chavoshi, R, Seyyedsani, N, Aghaei, E, Taheri, E, et al.. Enhanced anticancer potency of hydroxytyrosol and Curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line. Environ Toxicol 2021;36:1043\u201351. https:\/\/doi.org\/10.1002\/tox.23103.","DOI":"10.1002\/tox.23103"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_008","doi-asserted-by":"crossref","unstructured":"Lee, SY, Hong, EH, Jeong, JY, Cho, J, Seo, JH, Ko, HJ, et al.. Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma. Biomater Sci 2019;7:4624\u201335. https:\/\/doi.org\/10.1039\/c9bm00895k.","DOI":"10.1039\/C9BM00895K"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_009","doi-asserted-by":"crossref","unstructured":"Maroufi, NF, Vahedian, V, Akbarzadeh, M, Mohammadian, M, Zahedi, M, Isazadeh, A, et al.. The Apatinib inhibits breast cancer cell line MDA-MB-231 in\u00a0vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-\u03baB (NF-\u03baB) and mitogen-activated protein kinase (MAPK) signaling pathways. Breast Cancer 2020;27:613\u201320. https:\/\/doi.org\/10.1007\/s12282-020-01055-6.","DOI":"10.1007\/s12282-020-01055-6"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_010","doi-asserted-by":"crossref","unstructured":"Zhang, H. Apatinib for molecular targeted therapy in tumor. Drug Des Dev Ther 2015;9:6075. https:\/\/doi.org\/10.2147\/dddt.s97235.","DOI":"10.2147\/DDDT.S97235"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_011","doi-asserted-by":"crossref","unstructured":"Hu, X, Cao, J, Hu, W, Wu, C, Pan, Y, Cai, L, et al.. Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer. BMC Cancer 2014;14:820. https:\/\/doi.org\/10.1186\/1471-2407-14-820.","DOI":"10.1186\/1471-2407-14-820"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_012","doi-asserted-by":"crossref","unstructured":"Maroufi, NF, Rashidi, M, Vahedian, V, Jahanbazi, R, Mostafaei, S, Akbarzadeh, M, et al.. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line. Breast Cancer 2022;29:260\u201373. https:\/\/doi.org\/10.1007\/s12282-021-01310-4.","DOI":"10.1007\/s12282-021-01310-4"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_013","doi-asserted-by":"crossref","unstructured":"Taheri, E, Ghorbani, S, Safi, M, Sani, NS, Amoodizaj, FF, Heidari, M, et al.. Inhibition of colorectal cancer cell line CaCo-2 by essential oil of eucalyptus camaldulensis through induction of apoptosis. Acta Med Iran 2020;58:260\u20135. https:\/\/doi.org\/10.18502\/acta.v58i6.4051.","DOI":"10.18502\/acta.v58i6.4051"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_014","doi-asserted-by":"crossref","unstructured":"Hajazimian, S, Maleki, M, Mehrabad, SD, Isazadeh, A. Human Wharton\u2019s jelly stem cells inhibit endometriosis through apoptosis induction. Reprod 2020;159:549\u201358. https:\/\/doi.org\/10.1530\/rep-19-0597.","DOI":"10.1530\/REP-19-0597"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_015","doi-asserted-by":"crossref","unstructured":"Abbasi, S, Bazyar, R, Saremi, MA, Alishiri, G, Seyyedsani, N, Jadid, MF, et al.. Wharton jelly stem cells inhibits AGS gastric cancer cells through induction of apoptosis and modification of MAPK and NF-\u03baB signaling pathways. Tissue Cell 2021;73:101597. https:\/\/doi.org\/10.1016\/j.tice.2021.101597.","DOI":"10.1016\/j.tice.2021.101597"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_016","doi-asserted-by":"crossref","unstructured":"Li, J, Qin, S, Xu, J, Xiong, J, Wu, C, Bai, Y, et al.. Randomized, double-blind, placebo-controlled phase III trial of Apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol 2016;34:1448\u2013544. https:\/\/doi.org\/10.1200\/jco.2015.63.5995.","DOI":"10.1200\/JCO.2015.63.5995"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_017","doi-asserted-by":"crossref","unstructured":"Jin, Z, Cheng, X, Feng, H, Kuang, J, Yang, W, Peng, C, et al.. Apatinib inhibits angiogenesis via suppressing Akt\/GSK3\u03b2\/ANG signaling pathway in anaplastic thyroid cancer. Cell Physiol Biochem 2017;44:1471\u201384. https:\/\/doi.org\/10.1159\/000485583.","DOI":"10.1159\/000485583"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_018","doi-asserted-by":"crossref","unstructured":"Lai, HW, Chien, SY, Kuo, SJ, Tseng, LM, Lin, HY, Chi, CW, et al.. The potential utility of Curcumin in the treatment of HER-2-overexpressed breast cancer: an in\u00a0vitro and in\u00a0vivo comparison study with herceptin. Evid Based Complement Altern Med 2012;2012.","DOI":"10.1155\/2012\/486568"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_019","doi-asserted-by":"crossref","unstructured":"Yang, H, Huang, S, Wei, Y, Cao, S, Pi, C, Feng, T, et al.. Curcumin enhances the anticancer effect of 5-fluorouracil against gastric cancer through down-regulation of COX-2 and NF-\u03baB signaling pathways. J Cancer 2017;8:3697. https:\/\/doi.org\/10.7150\/jca.20196.","DOI":"10.7150\/jca.20196"},{"key":"2025121207235722323_j_hmbci-2022-0036_ref_020","doi-asserted-by":"crossref","unstructured":"Calaf, GM, Ponce-Cusi, R, Carri\u00f3n, F. Curcumin and paclitaxel induce cell death in breast cancer cell lines. Oncol Rep 2018;40:2381\u20138. https:\/\/doi.org\/10.3892\/or.2018.6603.","DOI":"10.3892\/or.2018.6603"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2022-0036\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2022-0036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:22:58Z","timestamp":1765527778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2022-0036\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,9,26]]},"published-print":{"date-parts":[[2023,3,30]]}},"alternative-id":["10.1515\/hmbci-2022-0036"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2022-0036","relation":{},"ISSN":["1868-1891"],"issn-type":[{"value":"1868-1891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}